LifeMine Therapeutics
Cambridge · Founded 2016
About LifeMine Therapeutics
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. LifeMine’s Avatar-Rx platform integrates high-throughput microbiology, data science and machine learning, genome engineering, and automation technologies to search the fungal biosphere for novel GEMs having a predetermined target and biological function. The platform integrates chemoinformatic-assisted drug optimization and state-of-the-art chemical synthesis with biotransformation to advance new product candidates into development. Founded by Gregory Verdine, PhD, Rick Klausner, MD, and WeiQing Zhou, MBA. LifeMine Therapeutics is headquartered in Cambridge, Massachusetts.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $295.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2022)
- Website: http://www.lifeminetx.com
- Phone: 617.665.5000
Industries & Categories
Biotechnology, Genetics, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lifemine-therapeutics-94811 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.